Introduction An Antibody-Drug Conjugate (ADC) is a precision cancer therapy that harnesses the specificity of a monoclonal antibody to target cancer cells linking it to a potent cytotoxic drug via a chemical linker. This targeted design enables the antibody to selectively bind to cancer cells delivering the drug payload directly to the tumor site while […]
Introduction An Antibody-Drug Conjugate (ADC) is a precision cancer therapy that harnesses the specificity of a monoclonal antibody to target cancer cells linking it to a potent cytotoxic drug via
Recombinant Monoclonal Antibodies for Therapeutic Use Recombinant monoclonal antibodies are one of the most promising drugs (immunotherapy) for human diseases, including infectious diseases, cancer, and various other conditions. Mammalian cells
